Fatty acid synthase (Fasn) is a key component of energy metabolism that is dynamically induced by food intake. Although extensive studies have revealed a number of transcription factors involved in the fasting/refeeding transition of Fasn expression in hepatocytes, much less evidence is available for adipocytes. Using the in vivo Ad-luc analytical system, we identified the inverted CCAAT element (ICE) around À100 nucleotides in the Fasn promoter as a critical cis-element for the refeeding response in adipocytes. Electrophoretic mobility shift assays and chromatin immunoprecipitation show that nuclear factor Y (NF-Y) binds to ICE specifically in refeeding states. Notably, the NF-Y binding to ICE is differently regulated between adipocytes and hepatocytes. These findings provide insights into the specific mechanisms controlling energy metabolism in adipocytes.
Fatty acid synthase (Fasn) is a key component of energy metabolism that is dynamically induced by food intake. Although extensive studies have revealed a number of transcription factors involved in the fasting/refeeding transition of Fasn expression in hepatocytes, much less evidence is available for adipocytes. Using the in vivo Ad-luc analytical system, we identified the inverted CCAAT element (ICE) around À100 nucleotides in the Fasn promoter as a critical cis-element for the refeeding response in adipocytes. Electrophoretic mobility shift assays and chromatin immunoprecipitation show that nuclear factor Y (NF-Y) binds to ICE specifically in refeeding states. Notably, the NF-Y binding to ICE is differently regulated between adipocytes and hepatocytes. These findings provide insights into the specific mechanisms controlling energy metabolism in adipocytes.
Keywords: adipose tissue; fatty acid; transcription Fatty acids are essential constituents of all biological membrane lipids, and are at the same time important substrates for energy metabolism. Fatty acid synthase (FAS; gene name: Fasn) synthesizes the 16-carbon saturated fatty acid palmitate from malonyl-CoA [1] . The absolute requirement for FAS during embryonic development was shown by FAS global knockout mice; homozygous mice with a complete FAS deficiency were not born and heterozygotes displayed a high degree of embryonic lethality as well [2] . In contrast, a liver-specific FAS knockout model was viable, and when placed on high-carbohydrate fat-free diet, they showed a significant reduction in fat pad weight compared to wild-type mice [3] . Moreover, FAS chemical inhibitors have recently received much attention as antiobesity drugs [4, 5] as well as anticancer drugs [6, 7] . Thus, FAS as the composer of fatty acids, central building blocks of life, plays a pivotal role in a wide range of biological processes from embryonic development and energy metabolism to cancer pathogenesis [8, 9] .
As a key component of energy metabolism, the regulatory mechanism of Fasn gene expression has been extensively explored in the last two decades. In metabolic tissues, such as liver and white adipose tissue (WAT), it is well known that Fasn expression is dynamically induced by food intake as carbohydrates consumed in excess of caloric requirements is Abbreviations ChIP, chromatin immunoprecipitation; ChREBP, carbohydrate-response-element-binding protein; EMSA, electrophoretic mobility shift assay; FAS, fatty acid synthase; ICE, inverted CAATT element; NF-Y, nuclear factor Y; SREBP, sterol regulatory element-binding protein; USF, upstream stimulatory factor; WAT, white adipose tissue.
converted into triglycerides for subsequent storage [10] [11] [12] . A number of previous studies have shown that transcription factors, such as sterol regulatory elementbinding protein-1 (SREBP-1), liver X receptor, upstream stimulatory factor (USF) and carbohydrateresponse-element-binding protein (ChREBP) exert significant control on Fasn expression in liver (reviewed in [13] ). There are also a few reports on the involvement of nuclear factor Y (NF-Y) and stimulatory protein 1 in hepatocytes [14] [15] [16] . However, much less evidence is available for adipocytes.
Previously, we reported that Fasn expression in the WAT of leptin-deficient ob/ob mice was profoundly decreased, whereas that in the liver was not altered compared with wild-type control [17] . Similar results were reported in high-fat diet-induced obese mouse model [18] . Consistently, it is reported that subjects with established obesity have an increased hepatic lipogenesis that could contribute to their excessive fat mass but decreased expression of lipogenic gene in adipose tissue in human obesity [19, 20] , indicating that Fasn expression is differently controlled between liver and WAT.
In an effort to better understand the molecular basis of this differential regulation of Fasn expression between liver and WAT, we previously clarified a differential involvement of SREBP-1 between these tissues by showing that SREBP-1 is not committed to the regulation of lipogenesis in adipocytes [21] .
One of the reasons why studies on adipocytes have been limited is because handling of adipocytes is still difficult and they cannot be cultured ex vivo for long enough duration for the analysis of transcriptional regulation. In order to overcome this difficulty by directly assessing transcriptional activities in vivo, we have recently established a quantitative intraorgan assay system (in vivo Ad-luc analytical system) that utilizes adenovirus-mediated transduction of luciferase reporter gene into various tissues in living animals [22] . Using this new method, we succeeded in clarifying the upstream mechanism of lipogenic gene regulation in the in vivo liver [23] .
These situations prompted us to investigate the regulatory mechanism of Fasn expression in in vivo adipose tissue of living animals using the in vivo Ad-luc analytical system optimized for adipose tissue in the present study.
Materials and methods

Animals
C57BL/6J and ICR male mice (7-to 9-week-old) were purchased from CLEA (Tokyo, Japan). All animals were housed in a temperature-controlled environment with a 12-h light/dark cycle and given free access to standard laboratory diet (MF from Oriental Yeast, composed of 60% carbohydrate, 13% fat and 27% protein on a caloric basis) and water. For the fasting group, animals were starved 24 h, and for the refeeding group, they were refed for 24 h after a 24-h starvation. All animals studied were anesthetized and euthanized according to a protocol approved by the Tsukuba University Animal Care and Use Committee. All experiments were repeated more than twice and reproducibility was confirmed.
Construction of luciferase reporter plasmids
Various lengths of promoter from the rat Fasn gene attached with luciferase reporter (rFAS-Luc) was prepared as previously described [24] . The fragments of rFAS-Luc promoter were cut out of the pGL2-Basic vector with NheI and HindIII, and the inserts were ligated into pGL3-Basic vector at NheI and HindIII sites.
Generation of recombinant adenovirus
For generation of adenovirus, pENTR4-Luc vector (containing the multicloning site of pGL3-Basic including Luc gene) was constructed from the gateway entry vector pENTR4 (Invitrogen) and pGL3-Basic vector (Promega) as described previously [22, 23] . Briefly, the multicloning site and Luc gene was cut out of pGL3-Basic vector with NotI and SalI, and after both ends were blunted, it was subcloned into the pENTR4 vector at EcoRI site (blunted). For pENTR4-Fasn promoter-Luc vector, Fasn promoter region was cut out from rFAS-Luc vector with SacI and HindIII, and inserted into pENTR4-Luc vector at SacI and HindIII sites. Fasn promoter-Luc adenoviral plasmid was generated by homologous recombination between the subcloned pENTR4 plasmid and pAd promoterless vector using Clonase recombinase (Gateway system; Invitrogen). Similarly, SV40-promoter-Renilla control adenoviral plasmid was generated from pRL SV40-promoter vector (Promega). The Renilla reporter gene was cut out of pRL SV40-promoter vector with HindIII and BamHI (BamHI site was blunted), and inserted into pENTR4-pGL3 vector whose luciferase gene was removed with HindIII and EcoRV. After the transfection into 293A cells, adenoviruses were collected by CsCl gradient centrifugation.
In vivo Ad-luc analysis
In vivo Ad-luc analysis was performed based on the methods previously described [22, 23] with the following modification. Fasn promoter-Luc adenovirus (Ad-Fasn promoter-Luc) and SV40-promoter-Renilla adenovirus (Ad-SV40-Renilla) were mixed at the dose of 6.0 9 10 6 P.F.U.
each, diluted to 3 lL with PBS containing 10% glycerol and 1 mM MgCl 2 , and injected into epididymal fat pad of C57BL/6J mice instantly using microsyringe, microtube and 33 gauge needle. Eighteen days after the injection, mice were sacrificed in a fasted or refed state and adipose tissues were collected. For luciferase activity measurement, tissue samples were homogenized in reporter lysis buffer (Promega), and after centrifugation, luciferase activity in the supernatant was measured using a Pikka Gene assay kit (Toyo Ink, Tokyo, Japan) on a luminometer. For Renilla activity measurement, the same supernatant was mixed to Renilla lysis buffer (Promega), and Renilla luciferase activity was measured using the Renilla reporter assay system (Promega) on a luminometer and used as a control.
Nuclear protein extraction from adipose tissue and liver
Nuclear protein extract from adipose tissue of ICR mice was prepared as described previously [25] . Briefly, fresh adipose tissue was rinsed in ice-cold PBS, minced, and homogenized with 10 strokes of a dounce homogenizer in NDS buffer at 4°C (10 mM Tris-HCl at pH 7.5, 10 mM NaCl, 60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine, 14 mM b-mercaptoethanol, 0.5 mM EGTA, 2 mM EDTA, 0.5% NP-40, 1 mM dithiothreitol) supplemented with protease inhibitors. NP-40 concentration was increased to 1% and nuclei were pelleted at 700 g for 10 min, washed once with NDS buffer (1% NP-40), pelleted at 500 g for 10 min. Nuclear pellet was resuspended in a buffer containing 10 mM HEPES at pH 7.9, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.5 mM EDTA, and 25% glycerol supplemented with protease inhibitors, agitated with magnet gently for 1 h, and centrifuged by 100 000 g for 30 min. The supernatant was used as a nuclear extract. Nuclear protein extract from liver was prepared as described previously [26] .
Nuclear protein extraction from 3T3-L1 adipocytes
Cells were washed with PBS, resuspended in buffer A (10 mM HEPES at pH 7.9, 10 mM NaCl, 5 mM MgCl 2 , 0.5% NP-40 and protease inhibitors), incubated on ice for 30 min, and spinned down at 3300 r.p.m. for 5 min. Pellet was resuspended in buffer C (20 mM HEPES at pH 7.6, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA), rotated at 4°C for 20 min, and spinned down at 15 000 r.p.m. for 20 min. The supernatant was used as a nuclear extract.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was performed as previously described [27] . Briefly, the DNA probe was prepared by annealing two oligonucleotides, labeled with 
Chromatin immunoprecipitation assay
Nuclear fraction from ICR mouse adipose tissue was prepared as stated above. Chromatin immunoprecipitation (ChIP) after preparing nuclear fraction was performed as described previously [26, 28] . Briefly, each group of nuclear fraction was pooled and washed by ice-cold PBS containing protease inhibitors 12. 
Immunoblot analysis
Aliquots of nuclear extract proteins were subjected to SDS/ PAGE. Immunoblot analysis was performed using the ECL Western Blotting Detection System (GE Healthcare), followed by the detection using ChemiDoc TM XRS+ (BioRad, Hercules, CA, USA) and IMAGE LAB TM Software (BioRad). The primary antibody used for immunoblotting was anti-NF-Ya antibody (sc-10779).
mRNA quantification
Total RNA from cells and tissues was prepared using Sepasol-RNA I (Nacalai Tesque, Kyoto, Japan). For real-time PCR analysis, total RNA was used for cDNA synthesis (Invitrogen). Real-time PCR was performed using the ABI Prism 7300 System (Applied Biosystems, Framingham, MA, USA) with SYBR Green master mix (Roche Diagnostics, Penzberg, Germany). The primer sequences are as follows:
Other primers were described previously [23] . Data were analyzed using the comparative cycle threshold method, and mRNA expression was normalized to Rplp0 expression.
Statistical analyses
Data are expressed as means AE SEM. Differences between two groups were assessed using an unpaired two-tailed Student's t test. The differences were considered statistically significant at P < 0.05.
Results
Development of in vivo Ad-luc analytical system for adipose tissue White adipose tissue is vulnerable to mechanical stress and drying. There were some papers reporting overexpression of genes in adipose tissue using adenovirus [29] , although the usual injection methods that need the administration volume of 20-50 lL may damage the injected adipose tissue. After careful preliminary evaluation on needle size of injector and volume of administration, a small volume (as little as 3 lL) administration method using microsyringe, microtube and 33-gauge needle was found to be adequate for stable infection of adenovirus (Fig. S1A) . To avoid drying of WAT, we covered adipose tissue with gauze damped by normal saline. Using this method, endogenous Fasn gene upregulation by refeeding after fasting was kept intact (Fig. S1B) . Eighteen days after administration of 700 nucleotides Fasn promoter-Luc adenovirus, luciferase activity showed 5-to 30-fold increase at refeeding states compared to fasting states (data not shown). When we did the same experiment 5 days after adenovirus administration, luciferase activity showed only around 1.5-fold increase at refeeding states compared to fasting states (data not shown), despite endogenous Fasn mRNA in adipose tissue showed 10-to 100-fold increase. For sufficient elevation of luciferase activity on refeeding, it seems that duration of more than 2 weeks is required after administration of adenovirus. To visualize the infection of adenovirus injected by this method at cellular level, we administrated Ad-GFP. Adenovirus was spread only in adipocytes and was not visible in SV fraction of adipose tissue (Fig. S1C) .
In vivo Ad-luc deletion analysis of Fasn gene promoter
From À700 nucleotides to +1 promoter sequences of Fasn gene are well conserved among mammalian species, so we used those regions for the promoter analysis. The previously reported regulatory elements within À700 nucleotides region of the Fasn promoter are shown in Fig. 1A [16, [30] [31] [32] . Based on the information, various deletion constructs of the rat Fasn promoter were designed, adenoviruses containing these constructs were generated, and in vivo Ad-luc promoter analysis was performed. The results of promoter activity changes upon refeeding were shown in Fig. 1B . Full responses upon refeeding were observed with the construct longer than À118 nucleotides, but no refeeding responses were detected with the constructs shorter than À93 nucleotides. These experiments identified the promoter region between À118 and À93 nucleotides as a critical cis-element for refeeding response of the Fasn gene in adipocytes.
Identification of the transactivator as NF-Y
Next, we tried to identify the transcription factor acting on this critical cis-element. Previous papers reported that nuclear factor Y (NF-Y) binds to inverted CAATT element (ICE) located around À100 nucleotides on the rat Fasn promoter in hepatocytes [16, 33] . Based on this information, we first examined whether a radiolabeled DNA probe corresponding to À110/À86, which includes ICE, can bind to nuclear extract proteins from adipose tissue on fasting or refeeding conditions in EMSA. As shown in Fig. 2A , protein binding to the À110/À86 probe increased at refeeding states in adipose tissue, whereas that to the À73/À45 probe that contains À65 E-box/SRE did not.
In sharp contrast to this finding, nuclear protein extracts from liver exhibited no changes in binding to the À110/À86 probe between fasting and refeeding, suggesting different mechanisms of regulation between adipose tissue and liver. Next, we identified this band as NF-Y using anti-NF-Ya antibody (Fig. 2B) . This NF-Y binding to ICE was shown to be increased during the differentiation process of 3T3-L1 adipocytes (Fig. 2C) , despite the constant expression of NF-Ya protein during adipogenesis (data not shown). 
Differential binding of NF-Y between WAT and liver
In order to further confirm differential binding of NF-Y on the Fasn promoter between adipose tissue and liver, ChIP assay was performed. As shown in Fig. 3A , NF-Ya binding to the Fasn promoter markedly increased on refeeding states in adipose tissue, whereas that in liver did not. Notably, the protein or mRNA levels of NF-Ys in adipose tissues did not change by fasting or refeeding except for a slight increase only seen in NF-Yc (Fig. 3B,C) .
In vivo Ad-luc mutation analysis of ICE
Finally, the critical role of NF-Y and its binding to ICE was confirmed using in vivo Ad-luc mutation analysis; we made various mutations or deletions to the region from À104 to À93 nucleotides of À218 Fasn promoter adenoviral constructs (Table 1) . EMSA experiments confirmed that mutations actually disrupted binding to NF-Y (Fig. S2A ). As shown in Fig. 4 , mutations impairing NF-Y binding perfectly abolished the refeeding response in adipose tissue, demonstrating that the ICE is required for the refeeding response of Fasn gene in vivo.
We also examined other known elements in the À218 Fasn promoter. Mutations on À65 E-box/SRE exhibited significant influence on the refeeding response of Fasn gene, whereas mutation on À92 Sp binding site did not affect significantly the promoter activity (Fig. S3A) . The characteristics of these mutations were verified using EMSA (Fig. S2B-D) . NF-Y also bound to À65 probe, consistent with the previous report [15] . 
ChoRE does not enhance refeeding response of Fasn promoter
Because it was previously reported that ChREBP contributes to the mRNA elevation of lipogenic genes including FAS in WAT-Glut4-Tg mice [34] , we assessed the influence of carbohydrate-responsive element (ChoRE) on Fasn expression using our in vivo Ad-luc analytical system. ChoRE is located around À7200 nucleotides on the rat Fasn promoter [35] , although the site is not conserved among mammals including human. We attached the ChoRE to the À218 Fasn promoter-luciferase construct and examined whether the ChoRE enhances the refeeding response of Fasn promoter or not. As shown in Fig. S3B , addition of ChoRE did not enhance the refeeding response of Fasn promoter, indicating that ChoRE does not contribute to refeeding response of Fasn gene in vivo.
Discussion
This study has clearly demonstrated that NF-Y has a crucial role in the regulation of Fasn gene expression in adipocytes. Moreover, NF-Y binding to the Fasn promoter was differently controlled between adipocytes and hepatocytes during fasting/refeeding transition, suggesting adipocyte-specific mechanisms of Fasn expression (Fig. 5) . Although it was previously reported that NF-Y binding to the À100 ICE is Table 1 . List of ICE mutation or deletion constructs used in Fig. 4 . The mutations are shown in bold and ICE sequences are underlined. Fig. 4 . In vivo Ad-luc mutation analysis of ICE. In vivo Ad-luc mutation/deletion analysis was performed on À100 ICE. À218 Fasn promoter was mutated or deleted as indicated. Sequences of mutation and deletion constructs are listed in Table 1 . Values were corrected by Renilla activities, and fold changes of refed state against fasted state were shown (N = 3, *P < 0.05).
involved in the cAMP-mediated downregulation of Fasn transcription in hepatocytes [33] , the key role of NF-Y in the regulation of refeeding response in adipocytes was clarified in the present study for the first time. NF-Y (also known as CBP, CCAAT-box binding protein) is a ubiquitous heterotrimeric transcription factor composed of three components, NF-Ya, NF-Yb and NF-Yc. The NF-Yb and c subunits form a tight dimer, which offers a complex surface for NF-Ya association. The resulting trimer can then bind to DNA with high specificity and affinity. Thus, NF-Y binds to CCAAT motifs, one of the most common cis-acting element in the promoter and enhancer regions of eukaryote genes in direct (CCAAT) or reverse (ATTGG) orientation [36, 37] . Analysis of the À150/ +50 region of 21 000 human promoters revealed that 18% have a CCAAT box [38] . Studies of different mammalian genes have defined the role of the CCAAT motif and its binding partner NF-Y in transcription in specific cell types, which can be regulated by diverse cellular signaling or pathogenic conditions, such as mechanical stress [39] , endoplasmic reticulum (ER) stress [40] , cholesterol and fatty acid metabolism [41, 42] , cell cycle progression [43, 44] , proliferation [45] , DNA damage response [46] , apoptosis [47] , neurodegenerative disease [48] and cancer [49, 50] . Especially on metabolism, Benatti and coworkers thoroughly investigated the metabolic pathways influenced by NF-Y transcriptional activity by analyzing gene expression profile in Hela, HCT116 and H322 cells after inactivation of NF-Ya by shRNA interference and coupling these data with ENCODE available ChIP-seq data of NF-Ya and NF-Yb. From these studies, they obtained evidence that NF-Y activates glycolytic genes and de novo biosynthetic pathways of lipids as well as genes involved in the SOCG (serine, one carbon, glycine) and glutamine pathways and the biosynthesis of polyamines and purines, repressing mitochondrial respiratory genes [51] .
Recently, it was reported that the fat-specific NF-Y knockout mice develop a moderately severe lipodystrophy and have reduced expression of leptin and other fat-specific genes [52] , whereas a total body knockout of NF-Ya is lethal due to a failure of cell proliferation during in utero development [53] . Moreover, RNAi mediated knockdown of NF-Y interfered with adipogenesis in vitro. It is also reported that NF-Y is involved in the regulation of adiponectin expression in response to nutrients and in the course of adipocyte differentiation [54] . These series of evidence suggest that NF-Y has expanded functional roles in adipocytes.
In this study, we found that NF-Y binding to Fasn promoter is differently regulated between adipocytes and hepatocytes during fasting/refeeding transition. The molecular mechanisms underlying this difference are currently unknown. However, it is possible that NF-Y in adipocytes might be under some tissue-specific control and undergo changes in acetylation, phosphorylation and/or other modifications during feeding to mediate transcription activation of the Fasn gene. Of note, it is reported that p300 acetylates lysine residues of NF-Ya and consequently enhances NF-Y transcriptional activity [55] . It is also notable that NF-Ya can be phosphorylated by some kinases including cyclin-dependent kinase 2 on serine residues and these phosphorylations positively affect its ability to bind DNA, thus increasing NF-Y activity [44, 56] . It is also reported that amino acids analysis of NF-Y revealed the presence of putative mammalian target of rapamycin (mTOR) and p70-S6 kinase phosphorylation sites [57, 58] , although further investigation is needed to determine whether acetylation and/or phosphorylation is involved in this mechanism.
NF-
Regarding the extracellular signals that trigger the fasting/refeeding transition of Fasn expression, insulin is known to be an important factor [10] . In fact, mice with fat-specific disruption of the insulin receptor gene (FIRKO mice) had low fat mass, and the levels of Fasn expression were reduced in FIRKO adipocytes as compared to wild-type controls [59] . Therefore, our current findings imply some molecular link between insulin signaling pathway and NF-Y. In connection with this, it is reported that insulin activates the expression of stearoyl-CoA desaturase 1, a lipogenic enzyme catalyzing the next step of FAS, in liver via a signaling pathway that involves PI3-kinase and mTOR and the downstream transcription factor NF-Y [58] . It is also reported that NF-Y binding to À100 ICE on the Fasn promoter is responsible for mediating the effect of cAMP in hepatocytes [15, 33, 60] , but there is no information available on the molecular link between insulin signaling pathway and NF-Y in adipocytes. Given that the Fasn expression in the adipocytes of obese mice is decreased in the development of insulin resistance [17, 61] , this signaling pathway from insulin to NF-Y might be also important in the pathogenesis of obesity-related metabolic disorders, although further investigation is needed to prove this hypothesis.
As stated above, NF-Y plays a fundamental role in the control of cellular functions including metabolism. To mediate its function, it is well known that NF-Y frequently cooperates with specific transcriptional factors and cofactors able to modulate its activity [50] . As a NF-Y-interacting partner, SREBP-1 is established to be cooperating in the regulation of cholesterol and fatty acid metabolism in hepatocytes [16, 41, 42, [62] [63] [64] [65] . In fact, recent genome-wide scanning of SREBP-1 and NF-Y occupancy showed that 32% of SREBP-1 targets were occupied by NF-Y in HepG2 cells [66] . However, we and others previously reported that the Fasn expression in adipocytes is regulated independently of SREBP-1 in contrast to hepatocytes [12, 21, 67] . The current data showing that À65 E-box mutation that does not affect SREBP-1 binding (Fig. S2C) impaired the refeeding response in adipocytes (Fig. S3A) are consistent with the previous results that excluded the involvement of SREBP-1 in the regulation of Fasn expression in adipocytes.
USF1/2 are also known to be NF-Y-interacting partners [68] . It is reported that USF1/2 play key roles in the transcriptional regulation of the Fasn gene by feeding and insulin in hepatocytes [69] [70] [71] . Especially, in USF1 or USF2 knockout mice liver, induction of the Fasn gene by refeeding was severely impaired [72] , suggesting the pivotal role of USF1/2 in the refeeding response of Fasn expression in the liver. In adipocytes, it is also reported that mutation of the À65 E-box sequence abolished insulin response in 3T3-L1 adipocytes [73, 74] , consistent with our in vivo results (Fig. S3A) . However, our data showing that À65 SRE mutation that does not affect USF1 binding (Fig. S2C ) also impaired the refeeding response in adipocytes (Fig. S3A) imply the involvement of other factor than USF1 in the regulation of Fasn expression in adipocytes, although they do not exclude the possible presence of USF in the complex. Further evidence is needed to draw definitive conclusions.
In the present study, we started from À700 region of the rat Fasn promoter that are conserved among mammals, and based on the data from in vivo Ad-luc deletion analysis, we finally focused on À118 region because this region exhibited full response of refeeding (Fig. 1) . Previous study using chloramphenicol acetyltransferase (CAT) reporter transgenic mice reported that À278-Fasn-CAT transgenic mice showed much weaker induction by feeding in both liver and adipose tissue, and that À131-Fasn-CAT transgenic mice did not show any CAT expression either when fasted or refed [75] . One possible resolution to these conflicting data might lie in a potential problem of positional effects often seen in transgenic mouse model [76] ; the method using pronuclear injection of DNA to produce transgenic mice has limitations including uncontrollability of transgene integration site and transgene copy number, both of which have a profound effect on transgene expression in mice. In contrast, our method using in vivo Ad-luc analytical system can completely avoid these problems.
In summary, we found that NF-Y has a crucial role in the regulation of Fasn gene expression during fasting/refeeding transition of adipocytes, providing a clue to the specific mechanisms controlling energy metabolism in adipocytes.
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